Diabetes and Heart Research Centre
  • CME INDIA – News for Use
  • Explore DHRC – Hindi
    • Diabetes Insights Repository – Hindi
    • About DHRC – Hindi
  • Explore DHRC
    • Diabetes Insights Repository
    • About DHRC
  • Privacy and Content
Select Page
Therapeutic nihilism with use of SGLT 2-Inhibitors is not justified in Frail diabetic patients

Therapeutic nihilism with use of SGLT 2-Inhibitors is not justified in Frail diabetic patients

by CME Team | Aug 9, 2022 | CME INDIA - News for Use

It is well known that sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) reduce hospitalizations for heart failure (HF) and mortality in general older populations with type 2 diabetesIt is estimated that in people with diabetes 32–48% prevalence of frailty...

Categories

  • CME INDIA – News for Use
  • Diabetes Insights
  • Diabetes Insights-English

Recent Posts

  • Therapeutic nihilism with use of SGLT 2-Inhibitors is not justified in Frail diabetic patients
  • CME INDIA News-for-Use Launched
  • Important tips in diabetes
  • Prevent stroke in diabetes
  • Pregnancy and diabetes

By browsing this site you agree with our Privacy Policy and Content Policy

© 2022 D.H.R.C. Content on this site NOT to be treated as Medical Advice. Propelled by Dynamic Cognition.